California Public Employees Retirement System Aeglea Bio Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.03 - $7.95 $125,671 - $165,685	-20,841 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.32 - $8.38 $407,380 - $540,166	-64,459 Reduced 75.57%	20,841 $145,000
Q4 2020 Feb 02, 2021	SELL	$7.02 - $9.83 $12,636 - $17,694	-1,800 Reduced 2.07%	85,300 $671,000
Q3 2020 Nov 05, 2020	SELL	$6.51 - $9.33 $38,487 - $55,158	-5,912 Reduced 6.36%	87,100 $618,000
Q2 2020 Aug 12, 2020	BUY	$4.01 - $11.04 $208,568 - $574,212	52,012 Added 126.86%	93,012 $860,000
Q4 2019 Jan 27, 2020	BUY	$7.23 - $8.55 $296,430 - $350,550	41,000 New	41,000 $313,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account